Drug Shortage Report for SANDOZ LOSARTAN
| Report ID | 238338 |
| Drug Identification Number | 02313340 |
| Brand name | SANDOZ LOSARTAN |
| Common or Proper name | LOSARTAN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | LOSARTAN POTASSIUM |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100FCT |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-09-23 |
| Estimated end date | 2024-11-22 |
| Actual end date | 2024-11-18 |
| Shortage status | Resolved |
| Updated date | 2024-11-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2024-11-19 | English | Compare |
| v17 | 2024-11-18 | French | Compare |
| v16 | 2024-11-18 | English | Compare |
| v15 | 2024-11-11 | French | Compare |
| v14 | 2024-11-11 | English | Compare |
| v13 | 2024-11-04 | French | Compare |
| v12 | 2024-11-04 | English | Compare |
| v11 | 2024-11-04 | French | Compare |
| v10 | 2024-11-04 | English | Compare |
| v9 | 2024-10-15 | French | Compare |
| v8 | 2024-10-15 | English | Compare |
| v7 | 2024-10-07 | French | Compare |
| v6 | 2024-10-07 | English | Compare |
| v5 | 2024-09-30 | French | Compare |
| v4 | 2024-09-30 | English | Compare |
| v3 | 2024-09-24 | English | Compare |
| v2 | 2024-09-23 | French | Compare |
| v1 | 2024-09-23 | English | Compare |
Showing 1 to 18 of 18